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INTRODUCTION
Poor symptom management during the last 
days of life at home can cause considerable 
distress for patients, their families, and 
clinicians.1–5 In the UK, Australia, and 
New Zealand, the prescribing of injectable 
anticipatory medications is promoted 
to optimise symptom control in the last 
days of life in the community and prevent 
crisis hospital admissions.6–10 Anticipatory 
medications are prescribed and dispensed 
ahead of need to a named patient.6 These 
are kept in the home and are used by visiting 
doctors or nurses if the patient is unable 
to take oral medications and develops 
symptoms of pain, agitation, nausea and 
vomiting, or respiratory secretions when 
they are dying.6,7 The intervention is intended 
to ensure rapid access to medications, 
particularly out of hours when there can 
be added delays in sourcing medication.11,12 
Box 1 briefly describes standard practice 
in prescribing anticipatory medications in 
the UK. 
Previous research into anticipatory 
prescribing practice has primarily 
focused on the views and experiences of 
nurses.5,10,11,13,14 Nurses often report that 
they initiate anticipatory prescribing, 
requesting GPs prescribe the drugs weeks 
before likely need.5,10,11,13–15 Only two studies 
to date have investigated GPs’ views in 
any detail.13,16 GPs report prescribing drugs 
from a few days to short weeks before likely 
need, depending on their personal clinical 
preferences and the unpredictability of the 
patient’s illness.16 
Nurses consistently report some GPs 
to be reluctant to prescribe anticipatory 
medications.10,13,15,17 Prescribing drugs 
ahead of need raises safety concerns for 
GPs.13,16,18 The GP remains accountable for 
the drugs they have prescribed, including 
strong opioids, which may be in the home 
for weeks. Once prescribed, permission 
has been granted for nurses to use the 
drugs based on their clinical assessment 
that the person is dying and has distressing 
symptoms.10,11,19 Drugs are open to misuse 
if there is a history of drug abuse in the 
home or they are given in inappropriate 
doses by visiting clinicians.16
Nurses and GPs generally perceive that 
ready access to anticipatory medications 
provides patients and families with 
reassurance.5,11,20 Community nurses 
report tailoring conversations about drugs 
depending on their own confidence and their 
perception of patients’ and family members’ 
willingness to talk about end-of-life care.5 
What information GPs discuss with patients 
and families about anticipatory medications 
has not been investigated to date. This study 
explores GPs’ decision-making processes 
in the prescribing and use of anticipatory 
medications for patients at the end of life.
Abstract
Background
GPs have a central role in decisions about 
prescribing anticipatory medications to help 
control symptoms at the end of life. Little is 
known about GPs’ decision-making processes in 
prescribing anticipatory medications, how they 
discuss this with patients and families, or the 
subsequent use of prescribed drugs. 
Aim
To explore GPs’ decision-making processes in the 
prescribing and use of anticipatory medications 
for patients at the end of life.
Design and setting
A qualitative interview study with GPs working in 
one English county.
Method
Semi-structured interviews were conducted 
with a purposive sample of 13 GPs. Interview 
transcripts were analysed inductively using 
thematic analysis.
Results
Three themes were constructed from the 
data: something we can do, getting the timing 
right, and delegating care while retaining 
responsibility. Anticipatory medications were a 
tangible intervention GPs felt they could offer 
patients approaching death (something we can 
do). The prescribing of anticipatory medications 
was recognised as a harbinger of death for 
patients and their families. Nevertheless, GPs 
preferred to discuss and prescribe anticipatory 
medications weeks before death was expected 
whenever possible (getting the timing right). After 
prescribing medications, GPs relied on nurses to 
assess when to administer drugs and keep them 
updated about their use (delegating care while 
retaining responsibility).
Conclusion
GPs view anticipatory medications as key to 
symptom management for patients at the end of 
life. The drugs are often presented as a clinical 
recommendation to ensure patients and families 
accept the prescription. GPs need regular access 
to nurses and rely on their skills to administer 
drugs appropriately. Patients’ and families’ 
experiences of anticipatory medications, and their 
preferences for involvement in decision making, 
warrant urgent investigation.
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METHOD
Design 
This interpretive descriptive study21,22 was 
conducted in an English county with a 
mixture of urban and rural communities. 
Interviews were undertaken with 13 GPs 
practising in 13 different GP surgeries, about 
their views and experiences of decision 
making about end-of-life anticipatory 
medications. Potential participants were 
identified through publicly accessible 
information on GP practice websites. 
Purposive sampling sought GPs with a 
wide range of perspectives and experience, 
including geographical location and out-of-
hours work. 
Thirty-two potential participants were 
approached by letter inviting them to 
participate, with the study information sheet 
and reply form that requested information 
concerning the number of years worked 
as a GP and whether they had a particular 
interest in palliative care. Sixteen GPs 
replied to express interest in taking part. 
Data collection
Interviews were semi-structured, in 
depth, and conducted between June and 
December 2017 by one researcher, who is a 
clinical academic and community palliative 
care nurse with experience of conducting 
qualitative research. Participants took 
part in one-off audio recorded interviews 
that lasted 26–48 minutes. An interview 
guide explored participants’ perceived role 
in end-of-life care, their decision making 
about anticipatory medications in recent 
patient cases, and associated conversations 
with patients, their families, and other 
healthcare professionals. The interview 
guide was continually adapted in response 
to early data collection and analysis (see 
Supplementary data 1 for details).23
Twelve interviews were conducted 
face-to-face at the GP participants’ place 
of work or home address, and one was 
conducted by telephone. No new themes 
were identified after 11 interviews. However, 
two further interviews were undertaken 
to recruit participants with characteristics 
of interest and ensure a range of rich 
insights.23,24
Data analysis
Interview recordings were professionally 
transcribed verbatim and checked by 
the interviewer for accuracy. Data were 
interpreted inductively using Braun and 
Clarke’s six phases of thematic analysis:23 
data familiarisation; generating initial codes; 
constructing themes; reviewing potential 
themes; defining and naming themes; 
and producing the report. Transcripts 
were coded by hand and then using NVivo 
(version 11) by the interviewer. 
To help reflexivity and rigour in interpreting 
the data,25,26 a public contributor with some 
experience in thematic analysis but no 
clinical training, independently coded the 
first three transcripts: and then compared 
and reflected on the early coding decisions 
together with the interviewer. A second 
researcher also read six transcripts and 
provided new insights throughout the coding 
process. These iterative steps informed the 
interviewer’s interpretative analysis.23,27–29 
Data were synthesised to understand 
patterns and differences in GPs’ accounts. 
RESULTS
The sample comprised 10 GP principals 
(mean 16 years working as GP, range 
3–29 years) and three salaried GPs (mean 
5 years working as GP, range 2–10 years); 
five GPs also worked as out-of-hours 
doctors. Eight GPs were male and five 
female; five worked in urban practices, 
eight in rural settings. Four worked full-
time and nine part-time, and five described 
How this fits in 
The prescribing of anticipatory medications 
to provide symptom relief in last days of 
life care is recommended practice in the 
UK, Australia, and New Zealand. GPs 
have a central role in the prescribing of 
anticipatory medications, but little is known 
about their decision-making processes 
and how they discuss these with patients 
and families. This study found that GPs 
are keen to prescribe drugs weeks 
ahead of death even if they are unlikely 
to be needed. GPs often recall framing 
anticipatory medications as their clinical 
recommendation to ensure that the 
prescription is accepted by patients and 
their families. 
Box 1. Standard practice in prescribing anticipatory medications in 
the UK5,7,11,19,20
• Injectable drugs are pre-emptively prescribed to be administered ‘if needed’ to manage pain, agitation, 
nausea and vomiting, and respiratory secretions in the last days of life
• The drugs and doses prescribed vary depending on anticipated clinical need and local practice guidance, 
and may include sublingual lorazepam
• A box or bag containing the medications, needles and syringes, patient information sheet, and signed 
medication administration authorisation chart detailing doses to be given are kept in the patient’s home
• Visiting nurses or doctors make a clinical assessment before deciding whether to administer any 
medications
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themselves as having an interest in palliative 
care.
Three interconnected themes were 
constructed from the data (something 
we can do, getting the timing right, 
and delegating care while retaining 
responsibility), and are set out below. 
Pseudonyms are used throughout. 
Something we can do
Anticipatory medications represented 
a tangible intervention that GPs felt they 
could offer for patients approaching death 
when more active medical options became 
inappropriate: ‘something we can do’. All 
the GPs interviewed highlighted that it was 
essential to have the drugs in place as an 
insurance plan that could be used to provide 
end-of-life symptom relief if needed:
‘There’s no crystal ball and it’s better to 
have them in place than face some sort of 
crisis.’ (Dr Brown, GP)
Participants recalled finding it hard to 
accurately predict some patients’ likely death 
and symptom control needs, especially 
in fluctuating terminal illnesses such as 
advanced dementia or multiple illnesses 
and frailty. They generally prescribed drugs 
while patients were relatively stable, as 
it helped them manage the uncertainty. 
In some recalled cases, prescribed drugs 
remained in the home for months or went 
unused. This was not considered to be 
problematic, with potential risks perceived 
to be outweighed by the benefits of giving 
reassurance to patients, families, and 
clinicians:  
‘We’ve certainly had a few people we’ve 
prescribed them so early they’ve gone out of 
date, which is kind of a bit silly, but actually 
if it’s giving them an extra bit of insurance 
along the way then I guess that’s okay.’ (Dr 
Smith, GP)
GPs wanted to put drugs in place to 
prevent potential problems for patients, 
families, and their colleagues out of hours. 
However, the five participants working in 
out-of-hours periods were not reliant on 
anticipatory medications being in place. 
They all had other strategies to get 
medication quickly when needed, including 
carrying limited supplies of drugs with them 
or collecting medication ahead of visits if 
they felt the patient was likely to need them:
‘We carry diamorphine and midazolam in a 
little safe in the car … If you haven’t left the 
base yet, you can anticipate and take it.’ (Dr 
Cook, GP and out-of-hours doctor) 
Participants were working in, and 
promoted, a culture where it was desirable 
to plan for an expected death and prescribe 
drugs well ahead of time: 
‘One or two of the partners said, “I think 
it’s a problem thinking when to do it”. 
I said “Why? Why can’t you just leave it 
[anticipatory medications] gathering dust ... 
why can’t you do it early?”.’ (Dr Taylor, GP)
Anticipatory medications were also used 
as a sign to alert other visiting clinicians to 
the terminal nature of the patient’s condition. 
Electronic records were not always shared 
between services. Consequently, clinicians 
unfamiliar with the patient’s situation had 
limited information on which to base their 
assessments. Having the drugs in the home 
sent a clear sign that the focus of care 
should be on providing end-of-life symptom 
control. Their presence also enabled 
doctors who did not know the patient to 
make remote care decisions:  
‘I think in one way it makes life easier. 
Decisions can be made over the phone, 
then, with the district nurses. It makes it 
clear to everyone what’s going on, which I 
think is useful.’ (Dr Riplin, GP and out-of-
hours doctor)
Getting the timing right
The prescribing of anticipatory medications 
was recognised as a ‘harbinger of death’ for 
patients and their families: conversations 
needed handling with sensitivity and skill. 
Participants described some patients and 
families as pragmatic and willing to have 
the drugs in place, whereas others viewed 
their introduction as an unwelcome sign of 
approaching death:
‘I think some patients find it reassuring, 
other patients I think find it about as 
reassuring as seeing a coffin propped up 
in the corner of the room. It’s about being 
sensitive to the individual patients and their 
needs and their wants as well.’ (Dr French, 
GP)
Despite being aware of their symbolic 
significance, 12 participants recalled 
prescribing anticipatory drugs weeks 
before expected death. In contrast, one GP 
reported waiting until days before expected 
death and prescribed drugs when patients 
were unable to consistently swallow oral 
medication. Several GPs recalled cases 
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where they had made the decision to 
prescribe drugs when patients were 
symptom-free but their care had overtly 
changed from active treatment to end-
of-life care. These events stimulated GP 
decision making and made it easier to bring 
up the subject of anticipatory medications in 
the context of planning for end-of-life care:
‘I tend to do it [prescribe drugs] at the same 
time as we agree that we’re not going to 
resuscitate or admit someone to hospital.’ 
(Dr Aplin, GP)
GPs reported being receptive to nurses 
proactively requesting that they consider 
prescribing drugs. They also commented 
that it had become increasingly uncommon 
for community nurses to request drugs 
because community nursing services 
were so overstretched. All but one of the 
participants recalled that they would see the 
patient in person to judge for themselves 
if it was appropriate and acceptable to 
prescribe the drugs. One GP recalled there 
were occasions when they had prescribed 
drugs remotely at the request of nurses who 
they knew and trusted to have prescribing 
discussions with patients and families. 
Where patients were in nursing homes, the 
GPs relied on experienced nurses to prompt 
them to consider prescribing drugs: 
‘It’s easier when I’m in the nursing home 
with experienced nurses that are with 
a patient all the time. We can have a 
discussion, and then we decide, “No, we’ll 
do it [prescribe anticipatory medications] 
after the weekend, she’ll be okay, it doesn’t 
look like it’s imminent,” or, “Yes, let’s get 
everything ready before the weekend”.’ (Dr 
Cox, GP)
GPs reported that they typically assumed 
responsibility for initiating anticipatory 
prescribing conversations with patients 
and families. They described their 
discussions with patients and families 
about anticipatory medications being 
incorporated in end-of-life advanced care 
planning conversations exploring patient 
and family understanding of the prognosis, 
preferred place of care, and death, and do 
not attempt cardiopulmonary resuscitation 
decisions. Just how commonly GPs had 
these conversations was unclear because 
three participants struggled to recall a 
recent end-of-life care case. Most GPs were 
keen to get what were seen as potentially 
difficult end-of-life conversations out of the 
way early so that plans were in place. 
Then patients, families, and participants did 
not have to worry about having distressing 
conversations in the future: 
‘I like to have those conversations early. 
To get them out of the way sounds like I’m 
trying to avoid them, I think get them out of 
the way for their benefit so that they don’t 
have to, they can, there’s a lot to sort out, 
“let’s get it all sorted out and then enjoy the 
last time you have”.’ (Dr Matthews, GP and 
out-of-hours doctor)
GPs reported framing the idea of 
anticipatory medications in a way that 
matched their perceptions of the patient’s 
willingness to openly discuss death and 
dying. If patients and families voiced 
worries about dying in pain or distress, 
GPs described going into detail about 
what symptoms could occur and what 
anticipatory medications would do in 
specific situations. Conversely, if patients 
and families were perceived as being 
reluctant to consider what might happen 
during the dying process, GPs described 
providing minimal information about drugs 
and their role in care: 
‘My experiences of talking to them, they 
vary as to what the patients seem to want to 
know … I just sort of try and explain that it’s 
there as a sort of mini pharmacy for people 
who are qualified to be able to access and 
sort of improve things without having to sort 
of go through the process of trying to get 
hold of the chemist.’ (Dr Taylor, GP)
Despite often recalling that patients and 
families appreciated having anticipatory 
medications prescribed, it was evident 
that participants often expected patients 
and families to be ambivalent about having 
them issued. Ten GPs described presenting 
anticipatory medications as a clinical 
recommendation, while giving patients or 
their families the opportunity to opt out of 
having them. This allowed GPs to present 
an illusion of supporting patient choice 
when they were using varying tactics of 
persuasion. For example, Dr Baker recalled 
using their position of authority to convince 
patients and families to have the drugs in 
the home when they judged this was in their 
best interests: 
‘I’m sometimes a bit more paternalistic 
than I normally am. I would sometimes say 
“well actually these, this is the appropriate 
time and this needs to be something that 
we do”. So, I will sometimes slightly force 
that discussion and then take time to 
explain why but I would sometimes, kind 
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of use the doctor card.’ (Dr Baker, GP and 
out-of-hours doctor)
Delegating care while retaining 
responsibility 
GPs were aware that they remained 
responsible for anticipatory medications 
once prescribed, but had little knowledge 
or control over when they were used: 
‘I’ve prescribed it in a way to be used and I’d 
expect them to use it … I don’t think every 
time it’s used I need to know.’ (Dr Baker, GP 
and out-of-hours doctor)
Delegating to unknown nurses or doctors 
the responsibility for assessing when to 
administer drugs caused concern at times: 
‘There are some issues about writing up 
potentially life-terminating drugs if used in 
an inappropriate way … to be used at the 
discretion of a third party, with no connection 
between the third party who initiates them 
and the prescriber.’ (Dr French, GP)
GPs were more concerned that drugs 
might not be used when they were needed. 
They were frustrated when nurses did not 
recognise dying and failed to administer 
drugs to relieve symptoms: 
‘That was not a good death … she became 
acutely unwell and breathless quite suddenly. 
The son was very distressed because he 
was with her and didn’t understand what 
was happening, wasn’t able to be reassured 
by the [nursing home nurses] that she was 
dying ... They didn’t give her anything, they 
just called an ambulance.’ (Dr Jones, GP)
GPs were reluctant to leave controlled 
drugs in the home if there was a history 
of drug misuse in the family. If drugs were 
left in the home for extended periods, GPs 
would often rely on nurses to monitor 
for potential risks and provide feedback 
on whether the prescriptions remained 
appropriate: 
‘So, it’s just not leaving boxes and ampoules 
of medications, but doing it at a time when 
the support network has been built in … and 
assessing safety as well.’ (Dr Lewis, GP)
Having easy access to nurses was 
perceived to be crucial in facilitating 
good end-of-life care and the appropriate 
use of anticipatory medications. All 
participants highlighted the importance 
of being able to have telephone or face-
to-face conversations with nurses to get 
to know their skills and abilities, and to 
keep updated on patients’ end-of-life care. 
Structural changes to the community 
nursing service meant that nurses were no 
longer based in the same building as GPs 
and communications went via a centralised 
contact centre. Telephone and electronic 
messages had replaced face-to-face and 
informal routes of communication, which 
had previously facilitated close working 
relationships. GPs were frustrated with 
this new arrangement and believed it had 
a negative impact on interprofessional 
relationships, communication, and patient 
care: 
‘It’s potentially quite disjointed from the 
feedback we’ve had from patients … We 
moved from the district nurses being in the 
practice [who] we could see every day … to 
now calling a number and not knowing who 
we were going to speak to.’ (Dr Pegg, GP 
and out-of-hours doctor)
With less personal contact with community 
nurses, the GPs had become increasingly 
reliant on shared electronic patient records 
to review nursing care remotely. Participants 
reported being keen to also maintain regular 
interdisciplinary team meetings to discuss 
patients’ end-of-life care needs. They 
described increasing difficulty in ensuring that 
community nurses attended these meetings, 
commenting that patient care was suffering 
as a result. Despite these issues, the role of 
community nurses in end-of-life care was 
highly valued by the GPs who recognised that 
they prioritised these patients and worked 
hard to meet their needs:
‘I know that there’s a lot of criticism about 
the lack in district nursing support in 
general … but in terms of end-of-life I think 
they are really good because they are there 
whenever I have people.’ (Dr Lewis, GP)
DISCUSSION
Summary
This study found that GPs prefer to prescribe 
anticipatory medications weeks ahead of 
likely need whenever possible. They recall 
framing information about the drugs and 
their uses in ways that ensure that patients 
and families are willing to have them in 
the home. After prescribing anticipatory 
medicines, GPs rely on nurses to judge 
when to administer drugs and to keep them 
updated on patients’ end-of-life care.
Strengths and limitations 
This study offers new and detailed insights 
into GPs’ perceptions of their end-of-life 
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care prescribing and decision making, from 
in-depth interviews with a diverse group 
of GPs. Although limited to one English 
county, the mixture of urban and rural 
practice settings offers valuable insights 
that are transferable across the UK. 
The interviews reflect GPs’ accounts of 
their own practice, rather than detailing 
actual practice. Interviewees can focus on 
notable cases or present versions of events, 
which fit within acceptable professional 
norms.30 
The interviewer’s previous clinical role as 
a community palliative care nurse helped 
with understanding working cultures and 
aided participant–researcher rapport.28 To 
ensure data were not interpreted purely 
through the interviewer’s personal clinical 
lens, a public contributor and second 
researcher contributed to data analysis.23,28,31 
Key decision points in the analysis were 
also debated with two researchers to help 
achieve a comprehensive and reflexive 
analysis.23,29
Comparison with existing literature
GPs’ accounts of actively leading the 
decisions to prescribe anticipatory 
medications in this study challenge the 
published perspective that it is nurses who 
routinely decide when drugs should be 
issued.5,10,11,13,15 GPs have previously been 
presented as being cautious of prescribing 
anticipatory medications unless they are 
likely to be needed within days or short 
weeks.16 In contrast, the current study found 
that most GPs reported they commonly 
prescribe drugs weeks ahead of expected 
death. Participating GPs considered it 
important to have drugs available even if 
they were unlikely to be needed, reflecting 
national guidance,6,7 and the preferences 
of nurses.5,10,11,14 Accounts of prescribing 
drugs weeks or months ahead of death also 
reflected the prognostic challenges in end-
of-life care for patients increasingly dying of 
non-cancer conditions such as dementia, 
ischaemic heart disease, and multimorbidity 
in old age,16,32 for whom illness trajectories 
are commonly less predictable and the 
dying phase protracted.33,34
Leaving anticipatory medications in the 
home for extended periods of time raises 
safety concerns.16 Patient safety may be 
compromised if drugs are administered 
without a prior skilled clinical assessment 
to rule out any reversible causes, diagnose 
dying, and check that the prescription 
remains appropriate.11,12,18 A 2019 analysis 
of patient safety incident reports found a 
recurring lack of knowledge or skills in 
using anticipatory medications among out-
of-hours nursing and medical staff.35 
The current study is the first to identify 
that anticipatory medications are used as a 
sign to alert other visiting clinicians to the 
terminal nature of the patient’s condition. 
Having the drugs in place enabled doctors 
unfamiliar with the patient to make care 
decisions without visiting. Regular reviews 
by skilled clinicians who know the patient 
and their situation are a central component 
in high-quality end-of-life care.36–38 In a 
climate where there are increasing 
demands on overstretched GP and 
community nursing services,37,39,40 there 
is a danger that anticipatory medications 
may be used to substitute regular clinical 
reviews by familiar GPs and community 
nurses. These risks are exacerbated during 
the COVID-19 pandemic as medical reviews 
by telephone or video are becoming the 
norm.41 
Mirroring the findings of a study of 
community nurses’ experiences of 
anticipatory medication prescribing 
conversations,5 participating GPs reported 
that patients and families could view the 
drugs as an unwelcome reminder of 
approaching death. Community nurses 
reported that some patients were reluctant 
to have drugs prescribed as a result.5 
Patients and families may be more inclined 
to accept GPs’ recommendations because 
of a greater power imbalance in the 
doctor–patient relationship.42,43 GPs in the 
current study recalled framing anticipatory 
medications as a clinical recommendation, 
using persuasive language or their authority 
to ensure the prescription was accepted. 
Similar techniques of persuasion have 
been reported in studies investigating how 
clinicians’ selectively present information 
about end-of-life care interventions 
if patients are hesitant to accept care 
or reluctant to have detailed end-of-life 
discussions.44–46 
In the current study, once GP 
participants had prescribed anticipatory 
medications they left nurses to manage 
end-of-life care and decide if and when to 
administer the drugs. This matches with 
other researchers’ findings that GPs often 
assume the role of ‘medical consultant’, 
delegating day-to-day care to community 
nurses, and relying on them to access GP 
input only if needed.47,48 Previous research 
has found that established relationships 
of trust between GPs and nurses, respect 
for each other’s expertise, and ease of 
access to each other, is important in 
ensuring that anticipatory medications are 
prescribed and used appropriately.5,13 The 
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current study found that even when GPs 
have infrequent contact with community 
nurses and have limited knowledge of their 
skills, they still delegated care based on 
historical relationships of trust. However, 
relationships of trust are becoming 
increasingly difficult to establish and 
maintain as organisational changes have 
resulted in more distant and fragmented 
communication.13,49–51 This changing 
relationship could have negative impacts 
on established practices of anticipatory 
prescribing,5,13 and on GPs’ confidence in 
delegating day-to-day end-of-life care to 
community nurses.47–49
Implications for research and practice
Anticipatory medications are viewed 
as a key component in community end-
of-life practice. It has become culturally 
acceptable for GPs to prescribe anticipatory 
medications weeks or even months before 
death is expected, in part to address the 
uncertainties of when the dying phase will 
start.5,6,34 There is a risk that such advance 
anticipatory prescribing might hinder the 
recognition and treatment of reversible 
causes of symptoms, especially when 
decisions about care are made remotely, 
and in the absence of skilled clinical face-
to-face GP or specialist reviews of the 
patient.18,41 Accounts of using the presence 
of anticipatory medications to guide care 
decisions in lieu of adequate sharing of 
patient electronic care plans between 
services raises questions about patient 
safety. The safety of prescribing drugs 
weeks ahead of possible need warrants 
further research.12 
Robust integrated systems are needed 
across primary and community care 
services to ensure that drugs and doses 
are reviewed regularly and are only 
administered when clinically appropriate.6,18 
In order to feel comfortable delegating care 
once they have prescribed anticipatory 
medications, GPs need to have regular 
contact with nurses and trust in their 
skills to administer drugs when clinically 
indicated. Informal routes of communication 
and regular interdisciplinary team meetings 
between GPs and nurses are also vital in 
maintaining strong working relationships 
and coordinating patient-centred end-of-
life care.5,13,49,50 
The way anticipatory medications are 
framed in GPs’ accounts of their prescribing 
conversations raises questions about how 
well informed patients and their families are 
about the drugs, potential side-effects, and 
their role in end-of-life care at home. Relying 
on clinicians’ assumptions that anticipatory 
medications provide reassurance risks 
misunderstanding patients’ and families’ 
concerns and wishes.5,52,53,54 No study to 
date has investigated patients’ views and 
experiences of anticipatory medications, and 
their preference for involvement in decision 
making.12 The authors have a study currently 
underway addressing this knowledge gap.
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